Dr. Dahl has more than 25 years of experience in product development including small molecules, biologics, cell therapy and devices.  Dr. Dahl has held senior management positions in several emerging companies.  He specializes in the operational responsibility for all aspects of R&D from benchtop through Phase 3 clinical trials. He has managed more than 40 clinical trials under multiple INDs and CTAs across a variety of therapeutic indications in numerous countries.